CitraNatal DHA DHA Soft Gel

Adult Female (18 - 50 Years) Lactating Pregnant Women NP How Supplied: Six child-resistant blister packs of 5 tablets and 5 soft gels each. Mission Pharmacal is a proud supporter of the March of Dimes. March of Dimes A fighting chance for every baby N NDC 0178-0894-30 Rx Only Please see side of carton for other important ingredients. In child-resistant packaging Storage: Store at 20 degrees C to 25 degrees C (68 degrees F to 77 degrees F), excursions permitted between 15 degrees C and 30 degrees C (between 59 degrees F and 86 degrees F). Brief exposure to temperatures up to 40 degrees C (104 degrees F) may be tolerated provided the mean kinetic temperature does not exceed 25 degrees C (77 degrees F); however, such exposure should be minimized. Dosage and administration: One tablet and one soft gel daily or as directed by a physician.

250 mg DHA Soft Gel Description: CitraNatal DHA is a prescription prenatal/postnatal multi-vitamin/mineral tablet with Ferr-Ease, a patented dual-iron delivery comprising both a quick release and slow release iron, and a capsule of an essential fatty acid. Quality ingredients, true comfort: 250 mg life'sDHA Indications: CitraNatal DHA is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, through pregnancy, and in the postnatal period for both lactating and nonlactating mother. The essential fatty acid DHA soft gel is caramel colored and contains a light yellow to orange semi-solid mixture. Trusted formulation

Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Notice: Contact with moisture can discolor or erode the tablet. Please consult your health care provider with any dietary concerns. To report a serious adverse event or obtain product information, call (800) 531-3333. Warning: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.